These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 16376805)

  • 21. Power Doppler ultrasound monitoring of response to anti-tumour necrosis factor alpha treatment in patients with rheumatoid arthritis.
    Iagnocco A; Finucci A; Ceccarelli F; Perricone C; Iorgoveanu V; Valesini G
    Rheumatology (Oxford); 2015 Oct; 54(10):1890-6. PubMed ID: 26070937
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical synovitis in a particular joint is associated with progression of erosions and joint space narrowing in that same joint, but not in patients initially treated with infliximab.
    Klarenbeek NB; Güler-Yüksel M; van der Heijde DM; Hulsmans HM; Kerstens PJ; Molenaar TH; de Sonnaville PB; Huizinga TW; Dijkmans BA; Allaart CF
    Ann Rheum Dis; 2010 Dec; 69(12):2107-13. PubMed ID: 20610442
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Improving outcomes in tumour necrosis factor a treatment: comparison of the efficacy of the tumour necrosis factor a blocking agents etanercept and infliximab in patients with active rheumatoid arthritis.
    De Filippis L; Caliri A; Anghelone S; Scibilia G; Lo Gullo R; Bagnato G
    Panminerva Med; 2006 Jun; 48(2):129-35. PubMed ID: 16953150
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Autoantibodies, metalloproteinases and bone markers in rheumatoid arthritis patients are unable to predict their responses to infliximab.
    Lequerré T; Jouen F; Brazier M; Clayssens S; Klemmer N; Ménard JF; Mejjad O; Daragon A; Tron F; Le Loët X; Vittecoq O
    Rheumatology (Oxford); 2007 Mar; 46(3):446-53. PubMed ID: 16899502
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Occupational therapy in rheumatoid arthritis: short term prospective study in patients treated with anti-TNF-alpha drugs].
    Pasqui F; Mastrodonato L; Ceccarelli F; Scrivo R; Magrini L; Riccieri V; Di Franco M; Gentili M; Valesini G; Spadaro A
    Reumatismo; 2006; 58(3):191-8. PubMed ID: 17013435
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Value of ultrasonography for diagnosis of synovitis associated with rheumatoid arthritis.
    Xiao H; Liu M; Tan L; Liao X; Li Y; Gao J; Li F; Xie X; Peng Q; Mao N; Tian J; Du J; Chen J
    Int J Rheum Dis; 2014 Sep; 17(7):767-75. PubMed ID: 24863714
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association of bone edema with the progression of bone erosions quantified by hand magnetic resonance imaging in patients with rheumatoid arthritis in remission.
    Lisbona MP; Pàmies A; Ares J; Almirall M; Navallas M; Solano A; Maymó J
    J Rheumatol; 2014 Aug; 41(8):1623-9. PubMed ID: 24986851
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Therapeutic efficacy of tocilizumab in patients with rheumatoid arthritis refractory to anti-tumor-necrosis-factor inhibitors: 1 year follow-up with low-field extremity MRI.
    Suzuki T; Horikoshi M; Sugihara M; Hirota T; Ogishima H; Umeda N; Kondo Y; Tsuboi H; Hayashi T; Chino Y; Matsumoto I; Sumida T
    Mod Rheumatol; 2013 Jul; 23(4):782-7. PubMed ID: 22975733
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dynamic contrast-enhanced, extremity-dedicated MRI identifies synovitis changes in the follow-up of rheumatoid arthritis patients treated with rituximab.
    Cimmino MA; Parodi M; Zampogna G; Boesen M; Kubassova O; Barbieri F; Paparo F; Garlaschi G; Cutolo M
    Clin Exp Rheumatol; 2014; 32(5):647-52. PubMed ID: 25068921
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Number of active joints, not diagnosis, is the primary determinant of function and performance in early synovitis.
    Gerber LH; Furst G; Yarboro C; el-Gabalawy H
    Clin Exp Rheumatol; 2003; 21(5 Suppl 31):S65-70. PubMed ID: 14969053
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of very early treatment in rheumatoid arthritis on bone oedema and synovitis, using magnetic resonance imaging.
    Kosta PE; Voulgari PV; Zikou AK; Tsampoulas K; Drosos AA; Argyropoulou MI
    Scand J Rheumatol; 2012 Oct; 41(5):339-44. PubMed ID: 22646866
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of in-office magnetic resonance imaging versus conventional radiography in detecting changes in erosions after one year of infliximab therapy in patients with rheumatoid arthritis.
    Gaylis NB; Needell SD; Rudensky D
    Mod Rheumatol; 2007; 17(4):273-8. PubMed ID: 17694258
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Power Doppler sonography monitoring of synovial perfusion at the wrist joints in patients with rheumatoid arthritis treated with adalimumab.
    Filippucci E; Iagnocco A; Salaffi F; Cerioni A; Valesini G; Grassi W
    Ann Rheum Dis; 2006 Nov; 65(11):1433-7. PubMed ID: 16504996
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Contrast-enhanced whole body joint MR imaging in rheumatoid patients on tumour necrosis factor-alpha agents: a pilot study to evaluate novel scoring system for MR synovitis.
    Kamishima T; Kato M; Atsumi T; Koike T; Onodera Y; Terae S
    Clin Exp Rheumatol; 2013; 31(1):154. PubMed ID: 23190694
    [No Abstract]   [Full Text] [Related]  

  • 35. Infliximab (chimeric anti-tumour necrosis factor alpha monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomised phase III trial. ATTRACT Study Group.
    Maini R; St Clair EW; Breedveld F; Furst D; Kalden J; Weisman M; Smolen J; Emery P; Harriman G; Feldmann M; Lipsky P
    Lancet; 1999 Dec; 354(9194):1932-9. PubMed ID: 10622295
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Persistent periodontal disease hampers anti-tumor necrosis factor treatment response in rheumatoid arthritis.
    Savioli C; Ribeiro AC; Fabri GM; Calich AL; Carvalho J; Silva CA; Viana VS; Bonfá E; Siqueira JT
    J Clin Rheumatol; 2012 Jun; 18(4):180-4. PubMed ID: 22647860
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Infliximab: an updated review of its use in Crohn's disease and rheumatoid arthritis.
    Keating GM; Perry CM
    BioDrugs; 2002; 16(2):111-48. PubMed ID: 11985485
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Delayed treatment with tumor necrosis factor inhibitors in incomplete responders to synthetic disease-modifying anti-rheumatic drugs shows an excellent effect in patients with very early rheumatoid arthritis with poor prognosis factors.
    Kita J; Tamai M; Arima K; Nakashima Y; Suzuki T; Kawashiri SY; Okada A; Koga T; Yamasaki S; Nakamura H; Origuchi T; Aramaki T; Nakashima M; Fujikawa K; Tsukada T; Ida H; Aoyagi K; Uetani M; Eguchi K; Kawakami A
    Mod Rheumatol; 2012 Apr; 22(2):195-201. PubMed ID: 21898075
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rheumatoid factor, but not anti-cyclic citrullinated peptide antibodies, is modulated by infliximab treatment in rheumatoid arthritis.
    De Rycke L; Verhelst X; Kruithof E; Van den Bosch F; Hoffman IE; Veys EM; De Keyser F
    Ann Rheum Dis; 2005 Feb; 64(2):299-302. PubMed ID: 15166003
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rapid reduction in tenosynovitis of the wrist and fingers evaluated by MRI in patients with rheumatoid arthritis after treatment with etanercept.
    Lisbona MP; Maymó J; Perich J; Almirall M; Carbonell J
    Ann Rheum Dis; 2010 Jun; 69(6):1117-22. PubMed ID: 20448287
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.